MissionIR's  Instablog

Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
My blog:
MissionIR Blog
  • VolitionRx Ltd. (VNRX) Sustains Ongoing Growth With Strong Business Strategy And Breakthrough Technology 0 comments
    Jan 6, 2014 2:11 PM | about stocks: VNRX

    VolitionRx is developing two types of non-invasive cancer diagnostic tests based on its patented Nucleosomics® technology. The company's overarching goal is to bring to market its cancer blood tests and revolutionize cancer diagnosis.

    While VolitionRx's current focus is on the detection of colorectal cancer, future plans call for expansion into detection of various other cancers as well. Following ongoing clinical trials and regulatory approval, the company plans to offer its tests for individualized cancers under the NuQ® brand.

    Backed by a scientific advisory board comprised of scientists from Europe, Asia, and the United States, VolitionRx is boldly progressing in the development of its cancer test, and in the next year expects to begin to get the results from its ongoing clinical trial involving 16,000 patients.

    In the near future, the company also anticipates receiving legal approval to sell its test in Europe, as well as start the process of U.S. FDA trials. Furthermore, VolitionRx looks forward to the second half of the year, at which time management hopes to uplist the company's stock to a major exchange.

    For more information, visit volitionrx.com or nucleosomics.com

    MissionIR provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.missionir.com

    Stocks: VNRX
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.